A panel of expert outside advisers to the U.S. FDA voted to recommend COVID-19 vaccine booster shots for Americans. Who are aged 65 and older and those at high risk of severe illness, after overwhelmingly rejecting a call for broader approval
In a second vote, an FDA panel recommended authorizing a Pfizer booster. For those 65 or older or at high risk of Covid. Earlier, the panel voted against recommending that they be authorized for everyone 16 or older.
An influential federal advisory panel rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans. The 16-2 vote was a blow to the Biden administration’s effort to increase virus protections amid the contagious delta variant.
What people are saying?
Meg Tirrell FDA then asked expert panel whether healthcare workers or others at high risk for occupational exposure be included in Pfizer/BioNTech booster EUA.
Dan Vergano Jonathan Sterne, University of Bristol, UK lays out wilderness of confounding factors in making sense of VE over time points to some hidden difference people getting vaccinated vs. unvaccinated. Rapid changes in surges changing denominator in studies. “Hard to study”.